Serial Number | 88369774 |
Word Mark | FUTURELYTICS |
Filing Date | Wednesday, April 3, 2019 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, March 20, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 17, 2019 |
Goods and Services | Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable computer software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; downloadable computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software |
Pseudo Mark | FUTURE LYTICS |
Goods and Services | Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; providing a website for electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 22, 2019 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 22, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Roche Molecular Systems, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | PLEASANTON, CA 94588 |
Party Name | Roche Molecular Systems, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Pleasanton, CA 94588 |
Event Date | Event Description |
Monday, March 20, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, March 20, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, August 9, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, August 8, 2022 | SOU EXTENSION 5 GRANTED |
Wednesday, July 27, 2022 | SOU EXTENSION 5 FILED |
Monday, August 8, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, July 27, 2022 | SOU TEAS EXTENSION RECEIVED |
Thursday, January 27, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, January 25, 2022 | SOU EXTENSION 4 GRANTED |
Tuesday, January 25, 2022 | SOU EXTENSION 4 FILED |
Tuesday, January 25, 2022 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 15, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, July 13, 2021 | SOU EXTENSION 3 GRANTED |
Tuesday, July 13, 2021 | SOU EXTENSION 3 FILED |
Tuesday, July 13, 2021 | SOU TEAS EXTENSION RECEIVED |
Saturday, January 30, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, January 28, 2021 | SOU EXTENSION 2 GRANTED |
Thursday, January 28, 2021 | SOU EXTENSION 2 FILED |
Thursday, January 28, 2021 | SOU TEAS EXTENSION RECEIVED |
Monday, October 19, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, October 19, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, October 19, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, October 19, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, October 19, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, August 13, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, August 11, 2020 | SOU EXTENSION 1 GRANTED |
Tuesday, August 11, 2020 | SOU EXTENSION 1 FILED |
Tuesday, August 11, 2020 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 11, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 17, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 17, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, November 27, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, November 27, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, November 27, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, November 11, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, October 11, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, October 11, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, October 10, 2019 | ASSIGNED TO LIE |
Friday, October 4, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, October 2, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, October 2, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, July 8, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 8, 2019 | NON-FINAL ACTION E-MAILED |
Monday, July 8, 2019 | NON-FINAL ACTION WRITTEN |
Thursday, June 13, 2019 | ASSIGNED TO EXAMINER |
Monday, April 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, April 6, 2019 | NEW APPLICATION ENTERED |